Immunobridging/Maintenance Therapy Versus Non-bridging Therapy in CAR-T Therapy for Low-risk R/R B-NHL
Clinical trial NCT06695013 · RECRUITING
Trial details
- NCT number
- NCT06695013
- Sponsor
- Ruijin Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-20
- Primary completion
- 2026-11-20
- Enrollment
- 144
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.